Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Recruiting1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT07156227Phase 1Recruiting
Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Recurrent Head and Neck Squamous Cell CarcinomaRecurrent Hypopharyngeal Squamous Cell Carcinoma+27 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Loren K Mell

NRG Oncology

Related
2 trials

Shared therapeutic areas:

Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Stage III Hypopharyngeal Carcinoma AJCC v8Stage III Laryngeal Cancer AJCC v8+10 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score13%

Eileen H Shinn

M.D. Anderson Cancer Center

Related
2 trials

Shared therapeutic areas:

Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Stage III Hypopharyngeal Carcinoma AJCC v8Stage III Laryngeal Cancer AJCC v8+7 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Nabil F. Saba, MD

Emory University

Related
2 trials

Shared therapeutic areas:

Recurrent Head and Neck Squamous Cell CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+3 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Clifton D Fuller

M.D. Anderson Cancer Center

Related
3 trials

Shared therapeutic areas:

Stage III Hypopharyngeal Carcinoma AJCC v8Stage III Laryngeal Cancer AJCC v8Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Siwen Hu-Lieskovan

SWOG Cancer Research Network

Related
2 trials

Shared therapeutic areas:

Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Stage III Hypopharyngeal Carcinoma AJCC v8Stage III Laryngeal Cancer AJCC v8+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

George Blumenschein, MD

M.D. Anderson Cancer Center

Related
5 trials

Shared therapeutic areas:

Recurrent Head and Neck Squamous Cell CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Paul M Harari

NRG Oncology

Related
2 trials

Shared therapeutic areas:

Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Stage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Athanassios (Ethan) Argiris

ECOG-ACRIN Cancer Research Group

Related
2 trials

Shared therapeutic areas:

Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Oropharyngeal Squamous Cell Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Kathryn M. Van Abel, MD

Mayo Clinic in Rochester

Related
2 trials

Shared therapeutic areas:

Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Recurrent Oropharyngeal Squamous Cell CarcinomaStage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Similarity Score3%

Shailender Bhatia, MD

Fred Hutch/University of Washington Cancer Consortium

Related
2 trials

Shared therapeutic areas:

Stage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8Stage IV Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8Unresectable Head and Neck Squamous Cell Carcinoma
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT07156227Phase 1PrincipalInvestigator

Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma

Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Recurrent Head and Neck Squamous Cell CarcinomaRecurrent Hypopharyngeal Squamous Cell Carcinoma+27 more
Recruiting

All 1 trials loaded